Schedule 13G ownership disclosure

Ampio Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 03209T109

Event date: 2015-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,692,500
Percent of class
7.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-16-092089
Form type
SC 13G/A
Filer
ACT CAPITAL MANAGEMENT, LLC
CIK
CIK 1442273
Filed
Jan 28, 2016
Reporting period
Dec 31, 2015
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub